Paul Vouros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paul Vouros has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
James Glick
Department of Chemistry and Chemical Biology and Barnett Institute, Northeastern University, Boston, MA 02115, USA
7 shared publicationsAdam B. Hall
Department of Chemistry and Chemical Biology, Northeastern University, Boston, MA, 02115, USA
3 shared publicationsQing Liao
Shenitech LLC Acton MA 01720 USA
3 shared publicationsAmol Kafle
Department of Chemistry and Chemical Biology and Barnett Institute, Northeastern University, 02115, Boston, MA, USA
2 shared publicationsChang Shen
Shenitech LLC Acton MA 01720 USA
2 shared publicationsJoshua J. Klaene
Department of Chemistry and Chemical Biology and Barnett Institute, Northeastern University, Boston, MA 02115, USA
2 shared publications
Latest Publications
- 9 May 2021
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 41 (6) , 938-944
David J. Harvey—Fifty years of memories
- 9 May 2021
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 41 (6) , 938-944
David J. Harvey—Fifty years of memories
- 16 November 2018
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 61 (24) , 11199-11208
Aliphatic Azides as Selective Cysteine Labeling Reagents for Integral Membrane Proteins
Upon ultraviolet activation, cannabinergic aliphatic azido (N3) ligands covalently label cannabinoid receptors, prominent G-protein coupled receptor (GPCR) drug targets. We report here the mechanism of covalent attachment to selected substrates of the high-affinity CBR inverse agonist AM1335 and its deuterated analog, AM1335(d10), arylpyrazole compounds with an azide moiety at their n-pentyl side chain. To model the receptor interaction, we synthesized the human cannabinoid 2 receptor (hCB2R) transmembrane helix 6 (TMH6) peptide and an N-acyl-protected cysteine (NAC). The photochemical reaction products of model substrates with AM1335 and AM1335(d10) were analyzed with tandem electrospray ionization-mass spectrometry fragmentation and deuterium exchange mass spectrometry. The nitrene initially formed after photoreaction undergoes rearrangement to an imine which then interacts with the cysteine sulfhydryl group, resulting in ligand attachment. Our results demonstrate that covalent probes carrying aliphatic azides behave more selectively than originally thought and can be used to label protein cysteine residues preferentially.
- 16 November 2018
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 61 (24) , 11199-11208
Aliphatic Azides as Selective Cysteine Labeling Reagents for Integral Membrane Proteins
Upon ultraviolet activation, cannabinergic aliphatic azido (N3) ligands covalently label cannabinoid receptors, prominent G-protein coupled receptor (GPCR) drug targets. We report here the mechanism of covalent attachment to selected substrates of the high-affinity CBR inverse agonist AM1335 and its deuterated analog, AM1335(d10), arylpyrazole compounds with an azide moiety at their n-pentyl side chain. To model the receptor interaction, we synthesized the human cannabinoid 2 receptor (hCB2R) transmembrane helix 6 (TMH6) peptide and an N-acyl-protected cysteine (NAC). The photochemical reaction products of model substrates with AM1335 and AM1335(d10) were analyzed with tandem electrospray ionization-mass spectrometry fragmentation and deuterium exchange mass spectrometry. The nitrene initially formed after photoreaction undergoes rearrangement to an imine which then interacts with the cysteine sulfhydryl group, resulting in ligand attachment. Our results demonstrate that covalent probes carrying aliphatic azides behave more selectively than originally thought and can be used to label protein cysteine residues preferentially.
- 8 July 2016
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 27 (10) , 1626-1636
Rapid and High-Throughput Detection and Quantitation of Radiation Biomarkers in Human and Nonhuman Primates by Differential Mobility Spectrometry-Mass Spectrometry
Radiation exposure is an important public health issue due to a range of accidental and intentional threats. Prompt and effective large-scale screening and appropriate use of medical countermeasures (MCM) to mitigate radiation injury requires rapid methods for determining the radiation dose. In a number of studies, metabolomics has identified small-molecule biomarkers responding to the radiation dose. Differential mobility spectrometry-mass spectrometry (DMS-MS) has been used for similar compounds for high-throughput small-molecule detection and quantitation. In this study, we show that DMS-MS can detect and quantify two radiation biomarkers, trimethyl-L-lysine (TML) and hypoxanthine. Hypoxanthine is a human and nonhuman primate (NHP) radiation biomarker and metabolic intermediate, whereas TML is a radiation biomarker in humans but not in NHP, which is involved in carnitine synthesis. They have been analyzed by DMS-MS from urine samples after a simple strong cation exchange-solid phase extraction (SCX-SPE). The dramatic suppression of background and chemical noise provided by DMS-MS results in an approximately 10-fold reduction in time, including sample pretreatment time, compared with liquid chromatography-mass spectrometry (LC-MS). DMS-MS quantitation accuracy has been verified by validation testing for each biomarker. Human samples are not yet available, but for hypoxanthine, selected NHP urine samples (pre- and 7-d-post 10 Gy exposure) were analyzed, resulting in a mean change in concentration essentially identical to that obtained by LC-MS (fold-change 2.76 versus 2.59). These results confirm the potential of DMS-MS for field or clinical first-level rapid screening for radiation exposure.
- 8 July 2016
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 27 (10) , 1626-1636
Rapid and High-Throughput Detection and Quantitation of Radiation Biomarkers in Human and Nonhuman Primates by Differential Mobility Spectrometry-Mass Spectrometry
Radiation exposure is an important public health issue due to a range of accidental and intentional threats. Prompt and effective large-scale screening and appropriate use of medical countermeasures (MCM) to mitigate radiation injury requires rapid methods for determining the radiation dose. In a number of studies, metabolomics has identified small-molecule biomarkers responding to the radiation dose. Differential mobility spectrometry-mass spectrometry (DMS-MS) has been used for similar compounds for high-throughput small-molecule detection and quantitation. In this study, we show that DMS-MS can detect and quantify two radiation biomarkers, trimethyl-L-lysine (TML) and hypoxanthine. Hypoxanthine is a human and nonhuman primate (NHP) radiation biomarker and metabolic intermediate, whereas TML is a radiation biomarker in humans but not in NHP, which is involved in carnitine synthesis. They have been analyzed by DMS-MS from urine samples after a simple strong cation exchange-solid phase extraction (SCX-SPE). The dramatic suppression of background and chemical noise provided by DMS-MS results in an approximately 10-fold reduction in time, including sample pretreatment time, compared with liquid chromatography-mass spectrometry (LC-MS). DMS-MS quantitation accuracy has been verified by validation testing for each biomarker. Human samples are not yet available, but for hypoxanthine, selected NHP urine samples (pre- and 7-d-post 10 Gy exposure) were analyzed, resulting in a mean change in concentration essentially identical to that obtained by LC-MS (fold-change 2.76 versus 2.59). These results confirm the potential of DMS-MS for field or clinical first-level rapid screening for radiation exposure.
- 1 March 2016
- Published by Elsevier in Journal of Chromatography A
- Vol. 1439, 112-123
Tracking matrix effects in the analysis of DNA adducts of polycyclic aromatic hydrocarbons
- 1 March 2016
- Published by Elsevier in Journal of Chromatography A
- Vol. 1439, 112-123
Tracking matrix effects in the analysis of DNA adducts of polycyclic aromatic hydrocarbons
- 23 January 2014
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 25 (7) , 1098-1113
Understanding Gas Phase Modifier Interactions in Rapid Analysis by Differential Mobility-Tandem Mass Spectrometry
A systematic study involving the use and optimization of gas-phase modifiers in quantitative differential mobility-mass spectrometry (DMS-MS) analysis is presented using nucleoside-adduct biomarker...
- 23 January 2014
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 25 (7) , 1098-1113
Understanding Gas Phase Modifier Interactions in Rapid Analysis by Differential Mobility-Tandem Mass Spectrometry
A systematic study involving the use and optimization of gas-phase modifiers in quantitative differential mobility-mass spectrometry (DMS-MS) analysis is presented using nucleoside-adduct biomarker...
- 25 June 2013
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 24 (9) , 1428-1436
Extending the Dynamic Range of the Ion Trap by Differential Mobility Filtration
A miniature, planar, differential ion mobility spectrometer (DMS) was interfaced to an LCQ classic ion trap to conduct selective ion filtration prior to mass analysis in order to extend the dynamic range of the trap. Space charge effects are known to limit the functional ion storage capacity of ion trap mass analyzers and this, in turn, can affect the quality of the mass spectral data generated. This problem is further exacerbated in the analysis of mixtures where the indiscriminate introduction of matrix ions results in premature trap saturation with non-targeted species, thereby reducing the number of parent ions that may be used to conduct MS/MS experiments for quantitation or other diagnostic studies. We show that conducting differential mobility-based separations prior to mass analysis allows the isolation of targeted analytes from electrosprayed mixtures preventing the indiscriminate introduction of matrix ions and premature trap saturation with analytically unrelated species. Coupling these two analytical techniques is shown to enhance the detection of a targeted drug metabolite from a biological matrix. In its capacity as a selective ion filter, the DMS can improve the analytical performance of analyzers such as quadrupole (3D or linear) and ion cyclotron resonance (FT-ICR) ion traps that depend on ion accumulation.
- 25 June 2013
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 24 (9) , 1428-1436
Extending the Dynamic Range of the Ion Trap by Differential Mobility Filtration
A miniature, planar, differential ion mobility spectrometer (DMS) was interfaced to an LCQ classic ion trap to conduct selective ion filtration prior to mass analysis in order to extend the dynamic range of the trap. Space charge effects are known to limit the functional ion storage capacity of ion trap mass analyzers and this, in turn, can affect the quality of the mass spectral data generated. This problem is further exacerbated in the analysis of mixtures where the indiscriminate introduction of matrix ions results in premature trap saturation with non-targeted species, thereby reducing the number of parent ions that may be used to conduct MS/MS experiments for quantitation or other diagnostic studies. We show that conducting differential mobility-based separations prior to mass analysis allows the isolation of targeted analytes from electrosprayed mixtures preventing the indiscriminate introduction of matrix ions and premature trap saturation with analytically unrelated species. Coupling these two analytical techniques is shown to enhance the detection of a targeted drug metabolite from a biological matrix. In its capacity as a selective ion filter, the DMS can improve the analytical performance of analyzers such as quadrupole (3D or linear) and ion cyclotron resonance (FT-ICR) ion traps that depend on ion accumulation.
- 1 June 2013
- Published by Elsevier in Cancer Letters
- Vol. 334 (1) , 10-19
The analysis of DNA adducts: The transition from 32P-postlabeling to mass spectrometry
- 1 June 2013
- Published by Elsevier in Cancer Letters
- Vol. 334 (1) , 10-19
The analysis of DNA adducts: The transition from 32P-postlabeling to mass spectrometry
- 21 May 2013
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 27 (13) , 1473-1480
A differential mobility spectrometry/mass spectrometry platform for the rapid detection and quantitation of DNA adduct dG‐ABP
RATIONALE: There is continued interest in exploring new analytical technologies for the detection and quantitation of DNA adducts, biomarkers which provide direct evidence of exposure and genetic damage in cells. With the goal of reducing clean‐up steps and improving sample throughput, a Differential Mobility Spectrometry/Mass Spectrometry (DMS/MS) platform has been introduced for adduct analysis. METHODS: A DMS/MS platform has been utilized for the analysis of dG‐ABP, the deoxyguanosine adduct of the bladder carcinogen 4‐aminobiphenyl (4‐ABP). After optimization of the DMS parameters, each sample was analyzed in just 30 s following a simple protein precipitation step of the digested DNA. RESULTS: A detection limit of one modification in 10^6 nucleosides has been achieved using only 2 µg of DNA. A brief comparison (quantitative and qualitative) with liquid chromatography/mass spectrometry is also presented highlighting the advantages of using the DMS/MS method as a high‐throughput platform. CONCLUSIONS: The data presented demonstrate the successful application of a DMS/MS/MS platform for the rapid quantitation of DNA adducts using, as a model analyte, the deoxyguanosine adduct of the bladder carcinogen 4‐aminobiphenyl. Copyright © 2013 John Wiley & Sons, Ltd.
- 21 May 2013
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 27 (13) , 1473-1480
A differential mobility spectrometry/mass spectrometry platform for the rapid detection and quantitation of DNA adduct dG‐ABP
RATIONALE: There is continued interest in exploring new analytical technologies for the detection and quantitation of DNA adducts, biomarkers which provide direct evidence of exposure and genetic damage in cells. With the goal of reducing clean‐up steps and improving sample throughput, a Differential Mobility Spectrometry/Mass Spectrometry (DMS/MS) platform has been introduced for adduct analysis. METHODS: A DMS/MS platform has been utilized for the analysis of dG‐ABP, the deoxyguanosine adduct of the bladder carcinogen 4‐aminobiphenyl (4‐ABP). After optimization of the DMS parameters, each sample was analyzed in just 30 s following a simple protein precipitation step of the digested DNA. RESULTS: A detection limit of one modification in 10^6 nucleosides has been achieved using only 2 µg of DNA. A brief comparison (quantitative and qualitative) with liquid chromatography/mass spectrometry is also presented highlighting the advantages of using the DMS/MS method as a high‐throughput platform. CONCLUSIONS: The data presented demonstrate the successful application of a DMS/MS/MS platform for the rapid quantitation of DNA adducts using, as a model analyte, the deoxyguanosine adduct of the bladder carcinogen 4‐aminobiphenyl. Copyright © 2013 John Wiley & Sons, Ltd.
- 20 September 2012
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 32 (1) , 72-86
The role of mass spectrometry in the analysis of vitamin D compounds
This review highlights the superseding role of mass spectrometry in the structural characterization and quantitation of vitamin D compounds in comparison to other analytical methods (e.g., UV, bioassays) that lack the sensitivity and specificity of mass spectrometry. After a short introduction to the biochemistry of vitamin D compounds, an overview of the current techniques to characterize and quantitate vitamin D compounds is given with emphasis on the contribution of mass spectrometry. © 2012 Wiley Periodicals, Inc., Mass Spec Rev 32:72–86, 2013
- 20 September 2012
- Published by Wiley in Mass Spectrometry Reviews
- Vol. 32 (1) , 72-86
The role of mass spectrometry in the analysis of vitamin D compounds
This review highlights the superseding role of mass spectrometry in the structural characterization and quantitation of vitamin D compounds in comparison to other analytical methods (e.g., UV, bioassays) that lack the sensitivity and specificity of mass spectrometry. After a short introduction to the biochemistry of vitamin D compounds, an overview of the current techniques to characterize and quantitate vitamin D compounds is given with emphasis on the contribution of mass spectrometry. © 2012 Wiley Periodicals, Inc., Mass Spec Rev 32:72–86, 2013
- 1 July 2012
- Published by Elsevier in Journal of Chromatography A
- Vol. 1245, 65-74
Reversed-phase ion-pair liquid chromatography electrospray ionization tandem mass spectrometry for separation, sequencing and mapping of sites of base modification of isomeric oligonucleotide adducts using monolithic column
- 1 July 2012
- Published by Elsevier in Journal of Chromatography A
- Vol. 1245, 65-74
Reversed-phase ion-pair liquid chromatography electrospray ionization tandem mass spectrometry for separation, sequencing and mapping of sites of base modification of isomeric oligonucleotide adducts using monolithic column